A-87515A

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameA-87515A
Drug Alias NameA-87515A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionATPase inhibitors
TargetsATPase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A